mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.03 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.03 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.03 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.04 |